The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors.

Authors: Gall, Gwenn Le, Cherifi, François, Divoux, Jordane, Florent, Romane, Christy, François, Leconte, Alexandra, San, Chankannira, Devillers, Amélie, Desmartin, Guillaume, Lecouflet, Lucie, Clarisse, Bénédicte, Ballesta, Samantha, Thorel, Lucie, Dubois, Brice, Harter, Valentin, Rousseau, Nathalie, Gaichies, Léopold, Martin-Françoise, Sandrine, Le Brun, Jean-François, Dolivet, Enora

Source: BMC Cancer; 2/11/2025, Vol. 24, p1-9, 9p

Subject Terms: HOMOLOGOUS recombination, MEDICAL sciences, ENDOMETRIAL cancer, COMBINATION drug therapy, POLY(ADP-ribose) polymerase